International Journal of Applied Science and Engineering
Published by Chaoyang University of Technology

Ganesh Prasad Mishra1*, Debadash Panigrahi2

1 Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Subhartipuram, Meerut, U.P, India
2 Drug Research Laboratory, Nodal Research Centre, College of Pharmaceutical Sciences, Puri, Odisha, India


 

Download Citation: |
Download PDF


ABSTRACT


The recent pandemic caused by SARS-CoV-2 is a major health concern for the entire world. Fast transmission and the mortality rate of this disease is a serious threat to human society. By looking into its seriousness finding medication against this disease is the biggest task of the present time. In the present study, computational approach is used to find effective compounds against SARS-CoV-2 infections. 1452 compounds having potential antiviral activity were selected from PubChem database to search potential inhibitors for the therapeutic targets of SARS-CoV-2. Molecular docking and absorption, distribution, metabolism, elimination and toxicity (ADMET) properties study were performed using Maestro 12.4 (Schrodinger Suite). All the selected compounds were funneled down to six compounds which are found to be effective against all the five targets of SARS-CoV-2. Among six compounds, compound C6 is exhibited excellent docking score -8.93, -8.21, -7.93, -6.73 kcal/mol with main protease (Mpro), angiotensin-converting enzyme-2 (ACE2), RNA dependent RNA polymerase (RdRp), and endoribonuclease (NSP15) target proteins respectively.


Keywords: Molecular docking, Computational screening, ADMET, COVID-19, Multi-target, SARS-CoV-2, Antiviral compounds.


Share this article with your colleagues

 


REFERENCES


  1. Azhar, E.I., Hui, D.S.C., Memish, Z.A., Drosten, C., Zumla, A. 2019. The middle east respiratory syndrome (MERS). Infectious Disease Clinics of North America, 33, 891–905.

  2. Benet, L.Z., Hosey, C.M., Ursu, O., Oprea, T.I. 2016. BDDCS, the Rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98.

  3. Bleicher, K.H., Bohm, H.J., Muller, K., Alanine, A.I. 2003. Hit and lead generation: beyond high-throughput   screening. Nature Reviews Drug Discovery, 2, 369–378.

  4. Elfiky, A.A. 2020. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life  Sciences, 253, doi: 10.1016/j.lfs.2020.118350

  5. Farmer, R., Gautam, B., Singh, S., Yadav, P.K., Jain, P.A. 2010. Virtual screening of AmpC/β-lactamase as target for antimicrobial resistance in Pseudomonas aeruginosa. Bioinformation, 4, 290–294.

  6. Genheden, S., Ryde, U. 2015. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10, 449–461.

  7. Giovanetti, M., Benvenuto, D., Angeletti, S., Ciccozzi, M. 2020. The first two cases of 2019-nCoV in Italy: where they come from. Journal Medical Virology, 92, 518–521.

  8. Hackbart, M., Deng, X., Baker, S.C. 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proceeding of the National Academy of Sciences, 117, 8094–8103.

  9. Hage-Melima, L.I.S., Federicob, L.B., Oliveiraa, N.K.S., Franciscoa, V.C.C., Correiaa, L.C., Limaa, H.B., Gomes, S.Q., Barcelos, M.P., Francischini, I.A.G., Paula da Silva C.H.T. 2020. Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19. Life Sciences, 256, doi: 10.1016/j.lfs.2020.117963
  10. Halgren, T.A., Murphy, R.B., Friesner, R.A., Beard, H.S., Frye, L.L., Pollard, W.T. 2004. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, Journal of Medicinal Chemistry, 47, 1750–1759.

  11. Heng, L., Shang, M.L., Xiao, H.Y., Shi, L.T., Chao, K.T. 2020. Coronavirus disease 2019 (COVID-19): current status and future perspectives. International Journal of Antimicrobial Agents, 55, doi: 10.1016/j.ijantimicag.2020.105951

  12. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497–506.

  13. Hui, D.S.C., Zumla, A. 2019. Severe acute respiratory syndrome: Historical, Epidemiologic, and Clinical Features. Infectious Disease Clinics of North America, 33, 869–889.

  14. Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M. 2020. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582, 289–293.

  15. Kord, A., Rabiee, B., Wang, S., Rostami, S., Gaba, R.C., Xie, K.L. 2020. A concise review and required precautions for COVID-19 outbreak in diagnostic and interventional radiology. Radiology Research and Practice, doi.org/10.1155/2020/7159091.

  16. Kumar, A., Rathi, E, Kini, S.G. 2019. E-pharmacophore modelling, virtual screening, molecular dynamics simulations and in-silico ADME analysis for identification of potential E6 inhibitors against cervical cancer. Journal of Molecular Structure,11289, 299–306.

  17. Sankar, V., Engel, S.E.M. 2018. Synthesis, biological evaluation, molecular docking and in silico ADME studies of phenacyl esters of N-Phthaloyl amino acids as pancreatic lipase inhibitors. Future Journal of Pharmaceutical Sciences, 4, 276–283.

  18. Vankadari, N. 2020. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. International Journal Antimicrobial Agents, 56, doi: 10.1016/ j.ijantimicag.2020.105998

  19. Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X.C., Liao, M., Rao, Z., Bartlam, M. 2008. Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82, 2515–2527.

  20. Yadav, P.K., Singh, G., Gautam, B., Singh S., Yadav, M., Srivastav, U., Singh, B. 2013. Molecular modeling, dynamic studies and virtual screening of Fructose 1,6–biphosphate aldose-II in community acquired-methicillin resistant Staphylococcus aureus (CA-MRSA). Bioinformation, 9, 158–164.

  21. Zhang, J., Shan, Y., Pan, X., Wang, C., Xu, W., He, L. 2011. Molecular docking, 3D-QSAR studies, and in silico ADME prediction of p-Aminosalicylic acid derivatives as neuraminidase inhibitors. Chemical Biology and Drug Design, 78, 709–717.


ARTICLE INFORMATION


Received: 2020-10-27

Accepted: 2020-12-31
Available Online: 2021-06-01


Cite this article:

Mishra, G.P., Panigrahi, D. 2021. Molecular docking and ADMET study for searching multi targeted antiviral compounds against SARS-CoV-2: A computational approach, International Journal of Applied Science and Engineering, 18, 2020273. https://doi.org/10.6703/IJASE.202106_18(2).004

  Copyright The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cited.